netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
News
News Title
news

Oct 18 - APC Position Statement: Lidocaine plasters for the treatment of post-herpetic neuralgia (licensed use), and focal neuropathic pain with allodynia (off-label)

    
04/10/2018
   
news

Oct 18 - New Drug Added to Formulary: Low dose desmopressin oral lyophilisate (Noqdirna®) for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults

    
02/10/2018
   
news

Aug 18 - SE London APC Recommendation: Levosert for heavy menstrual bleeding and contraception, and Kyleena for contraception

    
23/08/2018
   
news

Aug 18 - New Drug Added to Formulary: Intracinol ophthalmic suspension 40 mg in 1mL for visualising the vitreous in ophthalmology surgery, and inflammatory eye conditions

    
23/08/2018
   
news

Aug 18 - New Drug Added to Formulary: Bosentan tabs for segmental pulmonary arterial hypertension or failing Fontan

    
02/08/2018
   
news

Aug 18 - New Drug Added to Formulary: Sildenafil generic tabs for segmental pulmonary arterial hypertension or failing Fontan

    
02/08/2018
   
news

Jul 18 - SE London APC Patient Information: Freestyle Libre - Frequently Asked Questions for Patients

    
06/07/2018
   
news

Jul 18 - SE London APC Position Statement: Freestyle Libre position statement (updated)

    
06/07/2018
   
news

Jul 18 - APC Treatment Pathway: Psoriasis Biologic Drug Treatment

    
06/07/2018
   
news

Jun 18 - APC recommendationTriple combination therapy inhalers for adults with COPD: Trimbow®

    
28/06/2018
   
news

Jun 18 - APC recommendation:  Triple combination therapy inhalers for adults with COPD: Trelegy® Ellipta®

    
28/06/2018
   
news

Jun 18 - MHRA Drug Safety Update: Denosumab (Xgeva▼) for advanced malignancies involving bone: study data show new primary malignancies reported more frequently compared to zoledronate

    
28/06/2018
   
news

Jun 18 - MHRA Drug Safety Update: Denosumab (Xgeva▼) for giant cell tumour of bone: risk of clinically significant hypercalcaemia following discontinuation

    
28/06/2018
   
news

Jun 18 - MHRA Drug Safety Update: Dolutegravir (Tivicay▼, Triumeq▼, Juluca▼): signal of increased risk of neural tube defects; do not prescribe to women seeking to become pregnant; exclude pregnancy before initiation and advise use of effective contraception

    
28/06/2018
   
news

Jun 18 - APC guidance: South East London Guidance for Prescribing Enoxaparin in primary care

    
11/06/2018
   
news

Jun 18 - APC guidance: Emollients for adults and children

    
11/06/2018
   
news

May 18 - MHRA Drug Safety Update: Braltus (tiotropium): risk of inhalation of capsule if placed in the mouthpiece of the inhaler

    
11/06/2018
   
news

May 18 - APC treatment pathway: Management of Papulopustular Rosacea

    
22/05/2018
   
news

May 18 - APC recommendation:  Ivermectin cream (Soolantra™) for rosacea 

    
22/05/2018
   
news

May 18 - APC recommendation:  Doxycycline 40mg MR capsules (Efracea™) for rosacea

    
22/05/2018
   
news

May 18 - APC treatment pathway: Management of anal fissures

    
22/05/2018
   
news

May 18 - APC recommendation: Botulinum toxin in anal fissures

    
22/05/2018
   
news

May 18: APC guidance: Treatment of Wet Age-Related Macular Degeneration, Diabetic Macular Oedema, Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion 

    
01/05/2018
   
news

May 18 - APC recommendation: Estradiol gels (Oestrogel® and Sandrena®) for oestrogen deficiency symptoms in postmenopausal women

    
01/05/2018
   
news

Apr 18 - MHRA Drug Safety Update: Obeticholic acid (Ocaliva▼): risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment; reminder to adjust dosing according to liver function monitoring

    
30/04/2018
   
news

Apr 18 - MHRA Drug Safety Update: Valproate medicines (Epilim▼, Depakote▼): contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met 

    
30/04/2018
   
news

Apr 18 - SE London APC position statement (following MHRA advice): Ulipristal (Esmya) for fibroids

    
03/04/2018
   
news

Mar 18 - MHRA Drug Safety Update: Head lice eradication products: risk of serious burns if treated hair is exposed to open flames or other sources of ignition, eg, cigarettes

    
12/03/2018
   
news

Mar 18 - MHRA Drug Safety Update: Daclizumab (Zinbryta▼): suspension and recall for safety reasons; review patients as soon as possible and start alternative therapy

    
12/03/2018
   
news Feb 18 - MHRA Alert: Esmya (ulipristal acetate) for uterine fibroids: monitor liver function in current and recent users; do not initiate treatment in new users or those between treatment courses    
12/02/2018
   
news Feb 18 - MHRA Drug Safety Update: Misoprostol vaginal delivery system (Mysodelle): reports of excessive uterine contractions (tachysystole) unresponsive to tocolytic treatment    
07/02/2018
   
news Feb 18 - MHRA Drug Safety Update: Mycophenolate mofetil, mycophenolic acid: updated contraception advice for male patients    
07/02/2018
   
news Jan 18 - MHRA Drug Safety Update: Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (SCARs)    
10/01/2018
   
news Jan 18 - MHRA Drug Safety Update Daclizumab (Zinbryta▼) and risk of severe liver injury: new restrictions to use and strengthened liver monitoring     
10/01/2018
   
news Dec 17 - New Drug Added to Formulary Sucroferric oxyhydroxide (Velphoro® ) 500mg chewable tablets for the last line treatment of hyperphosphatemia in adult renal dialysis patients    
02/01/2018
   
news Dec 17 - MHRA Drug Safety Update: Fingolimod (Gilenya▼): new contraindications in relation to cardiac risk     
19/12/2017
   
news Dec 17 - MHRA Drug Safety Update: Gadolinium contrast agents and risk of tissue accumulation—removal of Omniscan and intravenous Magnevist from February; restrictions to use of other linear agents     
19/12/2017
   
news Dec 17 - MHRA Drug Safety Update: Fingolimod (Gilenya▼): updated advice about risk of cancers and serious infections     
19/12/2017
   
news Dec 17 - MHRA Drug Safety Update: Eluxadoline (Truberzi▼): risk of pancreatitis; do not use in patients who have undergone cholecystectomy or in those with biliary disorders     
19/12/2017
   
news Dec 17 - MHRA Drug Safety Update: Cladribine (Litak, Leustat) for leukaemia: reports of progressive multifocal encephalopathy (PML); stop treatment if PML suspected     
19/12/2017
   
news Nov 17 - MHRA Drug Safety Update: Quinine: reminder of dose-dependent QT-prolonging effects; updated medicine interactions    
30/11/2017
   
news Nov 17 - MHRA Drug Safety Update: Oral tacrolimus products: reminder to prescribe and dispense by brand name only    
30/11/2017
   
news Nov 17 - MHRA Drug Safety Update: Antiepileptic drugs: updated advice on switching between different manufacturers’ products    
30/11/2017
   
news Oct 17 - MHRA Drug Safety Update: Isotretinoin (Roaccutane): rare reports of erectile dysfunction and decreased libido    
31/10/2017
   
news Oct 17 - MHRA Drug Safety Update: Gabapentin (Neurontin): risk of severe respiratory depression    
31/10/2017
   
news Oct 17 - MHRA Drug Safety Update: Clozapine: reminder of potentially fatal risk of intestinal obstruction, faecal impaction, and paralytic ileus    
31/10/2017
   
news Oct 17 - MHRA Drug Safety Update: Methylprednisolone injectable medicine containing lactose (Solu-Medrone 40 mg): do not use in patients with cows’ milk allergy     
31/10/2017
   
news Oct 17 - APC recommendation: Oxybutynin (IR and MR) and propantheline for hyperhidrosis    
30/10/2017
   
news Oct 17 - APC PIL Freestyle Libre - Frequently asked questions for patients    
26/10/2017
   
news Oct 17 - APC interim position statement: FreeStyle Libre® Flash Glucose Monitoring system (not recommended for prescribing)    
26/10/2017
   
news Oct 17 - APC shared care guidance: Cinacalcet for Secondary Hyperparathyroidism in Adult End Stage Renal Disease Patients Established on Dialysis Therapy    
20/10/2017
   
news Oct 17 - APC recommendation Tioguanine for the treatment of adults with inflammatory bowel disease (off-label)    
10/10/2017
   
news Oct 17 - APC recommendation: Ferric maltol (Feraccru) for iron deficiency anaemia in adults with IBD    
10/10/2017
   
news Oct 17 - APC recommendation: Golimumab 100 mg for UC in adult patients weighing <80kg (off-label)    
10/10/2017
   
news Sep 17 - MHRA Drug Safety Update: Miconazole (Daktarin): over-the-counter oral gel contraindicated in patients taking warfarin    
09/10/2017
   
news Sep 17 - MHRA Drug Safety Update: Loperamide: reports of serious cardiac adverse reactions with high doses of loperamide associated with abuse or misuse    
09/10/2017
   
news Aug 17 - APC recommendation: Duavive (conjugated oestrogens and bazedoxifene) for oestrogen deficiency in the menopause    
04/09/2017
   
news Aug 17 - MHRA Drug Safety Update: Ibrutinib (Imbruvica▼): reports of ventricular tachyarrhythmia; risk of hepatitis B reactivation and of opportunistic infections    
16/08/2017
   
news Aug 17: MHRA Drug Safety Update: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration    
16/08/2017
   
news Aug 17 - MHRA Drug Safety Update: Adrenaline auto-injectors: updated advice after European review    
16/08/2017
   
news Aug 17: APC guidance: Management of Vitamin D Deficiency and Insufficiency in pregnancy and lactation     
15/08/2017
   
news Aug 17 - APC guidance: Management of Vitamin D Deficiency in ADULTS (excluding pregnant and breastfeeding patients)    
15/08/2017
   
news Jul 17 - APC recommendation: Collagenase (Xiapex®) for Peyronie’s disease (not approved)    
04/08/2017
   
news Jul 17 - APC recommendation: Botulinum toxin for achalasia    
04/08/2017
   
news Jul 17 - APC recommendation: Botulinum toxin for oesophageal spasm    
04/08/2017
   
news Jul 17 - MHRA Drug Safety Update: Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): reports of organ transplant rejection     
31/07/2017
   
news Jul 17 - MHRA Drug safety Update: Daclizumab (Zinbryta▼) and risk of severe liver injury: initiation in multiple sclerosis now restricted, promptly review patients already on treatment    
31/07/2017
   
news Jul 17 - MHRA Drug Safety Update: Bendamustine (Levact): increased mortality observed in recent clinical studies in off-label use; monitor for opportunistic infections, hepatitis B reactivation    
31/07/2017
   
news Jul 17 - APC shared care guidance: Prograf (tacrolimus caps) in adult liver transplant    
11/07/2017
   
news Jul 17 - APC shared care guidance: Mycophenolate mofetil in adult liver transplant    
11/07/2017
   
news Jul 17 - APC shared care guidance: Azathioprine in adult liver transplant    
11/07/2017
   
news Jul 17 - APC shared care guidance: Advagraf (tacrolimus MR caps) in adult liver transplant    
11/07/2017
   
news Jun 17 - APC recommendation: Moxifloxacin eye drops for bacterial keratitis    
23/06/2017
   
news Jun 17 - APC recommendation: Fluticasone propionate and azelastine combination nasal spray (Dymista) for allergic rhinitis    
23/06/2017
   
news Jun 17 - APC guidance: Allergic Rhinitis (adults and children)    
23/06/2017
   
news Jun 17 - APC guidance: Pharmacological management of Heart Failure    
23/06/2017
   
news Jun 17 - APC guidance: optimising prescribing for chronic stable angina    
08/06/2017
   
news May 17 - APC recommendation: Rivaroxaban for thromboprophylaxis post acetabular fracture (KCH only)    
06/06/2017
   
news May 17 - APC guidance: GLP-1 pathway for adults with type 2 diabetes    
11/05/2017
   
news May 17 - APC recommendation: Quadrivalent HPV vaccine (Gardasil®) for anogenital warts in adults     
11/05/2017
   
news Apr 17: MHRA Drug Safety Update: MS therapies: rebound effect after stopping or switching treatments    
08/05/2017
   
news Apr 17 - MHRA Drug Safety Update: Valproate and developmental disorders: further consideration of risk minimisation measures    
08/05/2017
   
news Mar 17 - APC treatment pathway: Pharmacological management of Restless Legs Syndrome - including new treatments    
04/04/2017
   
news Mar 17 - MHRA Drug Safety Update: SGLT2 inhibitors: updated advice on increased risk of lower-limb amputation    
29/03/2017
   

 

 

 

 


netFormulary